Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 27, 2024 11:11 ET | Source: The Akkermansia Company

Original Founders of Akkermansia Muciniphila Bring First Gut Health Product to U.S. Consumer Market

The Akkermansia Company, founded by the first scientists to discover and decode Akkermansia muciniphila, announces its launch into the U.S. consumer market
February 14, 2023 09:15 ET | Source: CMI

Global Next Generation Probiotics Market to Surpass US$ 393.9 Million by 2030, Says Coherent Market Insights (CMI)

Burlingame, Feb. 14, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global next generation probiotics market is estimated to be valued at US$ 168.1 million in 2022 and is...
December 02, 2021 10:00 ET | Source: Pan-Biome Pharmaceuticals, Inc

Pan-Biome Pharmaceuticals, Inc. provides update on its longevity research program: its compounds modulate inflammation, the gut microbiome, and increase lifespan of C. elegans by 30%

VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc., a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
February 24, 2021 10:00 ET | Source: Pan-Biome Pharmaceuticals, Inc

Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...